Literature DB >> 3103330

Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones.

B Asjö, I Ivhed, M Gidlund, S Fuerstenberg, E M Fenyö, K Nilsson, H Wigzell.   

Abstract

The monocytoid tumor cell line U-937 and five derived subclones were infected with the HTLV-IIIB isolate of the human immunodeficiency virus (HIV). Susceptibility to infection and sensitivity to the cytopathic effects correlated with the expression of the T4 antigen on the cell surface. On the basis of these characteristics the lines could be divided into three groups. Less than 10% T4 positive cells were present in the parental line and clone 4; hence productive infection could only be established after a long latency or with a high virus inoculum. These lines showed no or only marginal cytopathic effect. Clone 16 contained more than 95% T4 positive cells and was the most sensitive line to infection with HTLV-IIIB and its cytopathic effect. Cell death was so extensive following infection that no continuous virus producer line could ever be established from clone 16 cells. Cultures with intermediate T4 expression (50-70% T4+ cells) also had intermediate susceptibility to virus infection. Cytopathic changes, even if pronounced, could be overcome in the infected cultures by the addition of uninfected cells and, in each case, a producer line could be established. HTLV-IIIB infection of clone 16 cells could be blocked by preincubation with monoclonal anti-T4 antibodies indicating a close similarity between the HTLV-IIIB receptor on T4 positive T cells and monocytoid cells. The results thus show that T4 positive monocytoid cells can function as target cells for the HIV.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103330     DOI: 10.1016/0042-6822(87)90278-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  42 in total

1.  Internalization of CD4 molecules in human T-cells demonstrated by immuno-electron microscopy.

Authors:  J J Wang; C Hu; F Lee; M F Shaio; L K Chen
Journal:  Histochemistry       Date:  1992

2.  High frequency of isolation of defective human immunodeficiency virus type 1 and heterogeneity of viral gene expression in clones of infected U-937 cells.

Authors:  F Boulerice; S Bour; R Geleziunas; A Lvovich; M A Wainberg
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Expression of nef, vpu, CA and CD4 during the infection of lymphoid and monocytic cell lines with HIV-1.

Authors:  T Schneider; P Hildebrandt; K Rokos; U Schubert; W Rönspeck; C Grund; A Beck; R Blesken; G Kulins; H Oldenburg
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Disturbance of nuclear transport of proteins in CD4+ cells expressing gp160 of human immunodeficiency virus.

Authors:  Y Koga; M Sasaki; H Yoshida; M Oh-Tsu; G Kimura; K Nomoto
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

5.  Infection of the human monocytic cell line Mono Mac6 with human immunodeficiency virus types 1 and 2 results in long-term production of virus variants with increased cytopathogenicity for CD4+ T cells.

Authors:  J L'age-Stehr; M Niedrig; H R Gelderblom; J W Sim-Brandenburg; M Urban-Schriefer; E P Rieber; J G Haas; G Riethmüller; H W Ziegler-Heitbrock
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

6.  Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1.

Authors:  Y Y Lu; Y Koga; K Tanaka; M Sasaki; G Kimura; K Nomoto
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

7.  Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus type 1 gp160 to calmodulin.

Authors:  H Ishikawa; M Sasaki; S Noda; Y Koga
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

8.  Intracellular complexes of viral spike and cellular receptor accumulate during cytopathic murine coronavirus infections.

Authors:  P V Rao; T M Gallagher
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4.

Authors:  R A Byrn; I Sekigawa; S M Chamow; J S Johnson; T J Gregory; D J Capon; J E Groopman
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

10.  Two highly antigenic sites in the human immunodeficiency virus type 1 reverse transcriptase.

Authors:  E Björling; C A Boucher; A Samuelsson; T F Wolfs; G Utter; E Norrby; F Chiodi
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.